MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MAIA is expected to report earnings to fall 51.85% to -12 cents per share on March 23
Q4'25
Est.
$-0.13
Q3'25
Missed
by $0.08
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
The last earnings report on November 12 showed earnings per share of -27 cents, missing the estimate of -18 cents. With 214.69K shares outstanding, the current market capitalization sits at 37.40M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MAIA showed earnings on November 12, 2025. You can read more about the earnings report here.